Lipid Excipient Targets Multiple Dose Forms
A solid lipid excipient from ABITEC is designed for multiple dosing forms.
ABITEC Corporation, a manufacturer of specialty lipids, announced on Feb. 5, 2019 an expansion of its portfolio of excipients for multiple formulations. The new offering, CAPMUL GDB EP/NF, is a monographed glyceryl dibehenate designed for a range of dosing solutions.
The high-purity, highly-reproducible solid lipid excipient offers good flow and uniform particle size distribution for use in multiple formulations including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids, the company reports.
The company also offers specialty lipids for the manufacture of foams, creams, ointments, and lotions produced under cGMP manufacturing.
Source: Abitec
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
